Gateway 2011: Abbott Laboratories - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Abbott Laboratories


Your online Gateway to Abbott Laboratories in 2011

Abbott Laboratories
1401 Sheridan Road
North Chicago, IL 60064
1-800-240-1043
www.abbottcontractmfg.com



Abbott is a broad-based, global health care company devoted to the discovery, development, manufacture and marketing of products that span the continuum of care, from nutritionals and laboratory diagnostics through medical devices and pharmaceutical therapies. We advance leading-edge science and technologies that hold the potential for improving lives. And we’ve sustained our success by staying true to the key principles on which our company was founded more than a century ago: innovative care and a desire to make a meaningful difference in all that we do. As a world leader in pharmaceutical operations, Abbott can provide your company with global contract services to help you help you gain a competitive advantage. We work with partners who value quality healthcare as much as we do.

Join us at BIO (Abbott Booth: 2805) and CPhI (Abbott Booth: 42H39) in 2011 to learn more about our API and Contract Manufacturing Services.

Active Pharmaceutical Ingredients
-Multi compendia APIs (USP/EP/JP)

Biologics
-Cell line development
-Mammalian cell culture
-Process development
-Process characterization
-Pilot thru full scale commercial production

Finished Goods
-Manufacturing/Dosage
-Packaging

Potents/Cytotoxins
-Small scale production
-API commercial production
-Finished goods production

We invite you to partner with us as we help translate your science into healthier lives around the world.

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here